Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study.

Liccardi G, Calzetta L, Bilò MB, Brusca I, Cecchi L, Costantino MT, Da Re M, Buzzulini F, Giani M, Lombardi C, Meneguzzi G, Meriggi A, Milanese M, Onida R, Patella V, Pignatti P, Quercia O, Ridolo E, Sabatino G, Sacerdoti C, Savi E, Scala E, Steinhilber G, Villalta D, Passalacqua G, Rogliani P; Italian Allergic Respiratory Diseases Task Force.

J Allergy Clin Immunol Pract. 2020 Mar 12. pii: S2213-2198(20)30242-7. doi: 10.1016/j.jaip.2020.02.041. [Epub ahead of print] No abstract available.

PMID:
32173510
2.

Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review.

Calzetta L, Ritondo BL, Matera MG, Cazzola M, Rogliani P.

Expert Rev Respir Med. 2020 Mar 13. doi: 10.1080/17476348.2020.1743180. [Epub ahead of print]

PMID:
32168461
3.

The possible concomitant use of aeroallergen and food panels for skin prick testing might enhance the risk of generalized allergic reactions in children.

Liccardi G, Calzetta L, Milanese M, Apicella G, Rogliani P.

Turk J Pediatr. 2019;61(5):815-816. doi: 10.24953/turkjped.2019.05.027. No abstract available.

4.

TSLP Inhibitors for Asthma: Current Status and Future Prospects.

Matera MG, Rogliani P, Calzetta L, Cazzola M.

Drugs. 2020 Apr;80(5):449-458. doi: 10.1007/s40265-020-01273-4.

PMID:
32078149
5.

Anthelminthic medicinal plants in veterinary ethnopharmacology: A network meta-analysis following the PRISMA-P and PROSPERO recommendations.

Calzetta L, Pistocchini E, Leo A, Roncada P, Ritondo BL, Palma E, di Cave D, Britti D.

Heliyon. 2020 Feb 4;6(2):e03256. doi: 10.1016/j.heliyon.2020.e03256. eCollection 2020 Feb.

6.

Severe Asthma and Biological Therapy: When, Which, and for Whom.

Rogliani P, Calzetta L, Matera MG, Laitano R, Ritondo BL, Hanania NA, Cazzola M.

Pulm Ther. 2019 Dec 26. doi: 10.1007/s41030-019-00109-1. [Epub ahead of print] Review.

PMID:
32048241
7.

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses.

Cazzola M, Calzetta L, Rogliani P, Matera MG.

Pulm Ther. 2019 Dec;5(2):117-126. doi: 10.1007/s41030-019-00102-8. Epub 2019 Nov 2. Review.

8.

Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics.

Principe S, Benfante A, Calzetta L, Rogliani P, Scichilone N.

World Allergy Organ J. 2019 Nov 6;12(11):100081. doi: 10.1016/j.waojou.2019.100081. eCollection 2019 Nov.

9.

A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study.

Calzetta L, Matera MG, Goldstein MF, Fairweather WR, Howard WW, Cazzola M, Rogliani P.

Pulm Pharmacol Ther. 2020 Feb;60:101883. doi: 10.1016/j.pupt.2019.101883. Epub 2019 Dec 26.

10.

Pharmacology and Therapeutics of Bronchodilators Revisited.

Matera MG, Page CP, Calzetta L, Rogliani P, Cazzola M.

Pharmacol Rev. 2020 Jan;72(1):218-252. doi: 10.1124/pr.119.018150. Review.

PMID:
31848208
11.

Why Are Allergens Not Detected in the Bronchoalveolar Lavage Fluid of Patients Undergoing Fiberoptic Bronchoscopy? Possible Explanations.

Liccardi G, Calzetta L, Milanese M, Bilò MB, Rogliani P.

J Investig Allergol Clin Immunol. 2019 Dec;29(6):472-473. doi: 10.18176/jiaci.0429. No abstract available.

12.

Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo.

Rogliani P, Matera MG, Facciolo F, Page C, Cazzola M, Calzetta L.

Br J Pharmacol. 2020 Mar;177(5):1150-1163. doi: 10.1111/bph.14909. Epub 2020 Jan 29.

PMID:
31660611
13.

Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients.

Calzetta L, Matera MG, Cazzola M, Rogliani P.

Adv Ther. 2019 Dec;36(12):3291-3298. doi: 10.1007/s12325-019-01119-w. Epub 2019 Oct 25.

14.

The impact of comorbidities on severe asthma.

Rogliani P, Sforza M, Calzetta L.

Curr Opin Pulm Med. 2020 Jan;26(1):47-55. doi: 10.1097/MCP.0000000000000640.

PMID:
31644439
15.

Impact of ICS/LABA and LABA/LAMA FDCs on functional and clinical outcomes in COPD: A network meta-analysis.

Calzetta L, Di Marco F, Blasi F, Cazzola M, Centanni S, Micheletto C, Rossi A, Rogliani P.

Pulm Pharmacol Ther. 2019 Dec;59:101855. doi: 10.1016/j.pupt.2019.101855. Epub 2019 Oct 19.

PMID:
31639476
16.

Isolated airways in equine respiratory pharmacology: They never lie.

Calzetta L, Pistocchini E, Ritondo BL, Roncada P, Cito G, Britti D, Matera MG.

Pulm Pharmacol Ther. 2019 Dec;59:101849. doi: 10.1016/j.pupt.2019.101849. Epub 2019 Sep 22.

PMID:
31553927
17.

Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations.

Rogliani P, Matera MG, Ritondo BL, De Guido I, Puxeddu E, Cazzola M, Calzetta L.

Pulm Pharmacol Ther. 2019 Dec;59:101841. doi: 10.1016/j.pupt.2019.101841. Epub 2019 Sep 11.

PMID:
31520718
18.

Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD.

Cazzola M, Calzetta L, Rogliani P, Matera MG.

Expert Opin Investig Drugs. 2019 Oct;28(10):827-833. doi: 10.1080/13543784.2019.1661990. Epub 2019 Sep 1. Review.

PMID:
31474120
19.

Sensitization to Cat: Why Not Use Molecular Diagnostics instead of the Nasal Challenge in Clinical Practice?

Liccardi G, Calzetta L, Milanese M, Bilò MB, Rogliani P.

Int Arch Allergy Immunol. 2019;180(2):142-143. doi: 10.1159/000501796. Epub 2019 Aug 14. No abstract available.

PMID:
31412331
20.

Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis.

Rogliani P, Calzetta L, Ora J, Cazzola M, Matera MG.

Multidiscip Respir Med. 2019 Aug 3;14:25. doi: 10.1186/s40248-019-0189-0. eCollection 2019.

21.

Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment.

Matera MG, Rinaldi B, Calzetta L, Rogliani P, Cazzola M.

Pulm Pharmacol Ther. 2019 Oct;58:101828. doi: 10.1016/j.pupt.2019.101828. Epub 2019 Jul 23. Review.

PMID:
31349002
22.

Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients.

Rogliani P, Matera MG, Calzetta L, Hanania NA, Page C, Rossi I, Andreadi A, Galli A, Coppola A, Cazzola M, Lauro D.

Respir Med. 2019 Jul - Aug;154:86-92. doi: 10.1016/j.rmed.2019.06.015. Epub 2019 Jun 18.

PMID:
31228775
23.

Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics.

Cazzola M, Calzetta L, Page C, Rogliani P, Matera MG.

Trends Pharmacol Sci. 2019 Jul;40(7):452-463. doi: 10.1016/j.tips.2019.04.015. Epub 2019 May 27. Review.

PMID:
31147200
24.

Monoclonal antibodies for severe asthma: Pharmacokinetic profiles.

Matera MG, Calzetta L, Rogliani P, Cazzola M.

Respir Med. 2019 Jul;153:3-13. doi: 10.1016/j.rmed.2019.05.005. Epub 2019 May 13. Review.

PMID:
31136930
25.

Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.

Rogliani P, Matera MG, Page C, Puxeddu E, Cazzola M, Calzetta L.

Respir Res. 2019 May 27;20(1):104. doi: 10.1186/s12931-019-1078-y.

26.

Clinical efficacy of bronchodilators in equine asthma: Looking for minimal important difference.

Calzetta L, Crupi R, Roncada P, Pistocchini E, di Cave D, Rossi I, Cito G, Jacobson GA, Britti D.

Equine Vet J. 2020 Mar;52(2):305-313. doi: 10.1111/evj.13137. Epub 2019 Jul 1.

PMID:
31132169
27.

Monoclonal antibodies in severe asthma: is it worth it?

Calzetta L, Matera MG, Rogliani P.

Expert Opin Drug Metab Toxicol. 2019 Jun;15(6):517-520. doi: 10.1080/17425255.2019.1621837. Epub 2019 May 23.

PMID:
31104515
28.

Response.

Calzetta L, Cazzola M, Matera MG, Rogliani P.

Chest. 2019 May;155(5):1079-1080. doi: 10.1016/j.chest.2019.01.028. No abstract available.

PMID:
31060694
29.

Bronchodilators in subjects with asthma-related comorbidities.

Cazzola M, Rogliani P, Calzetta L, Matera MG.

Respir Med. 2019 May;151:43-48. doi: 10.1016/j.rmed.2019.04.001. Epub 2019 Apr 3. Review.

PMID:
31047116
30.

Cardiovascular Disease in Chronic Respiratory Disorders and Beyond.

Rogliani P, Cazzola M, Calzetta L.

J Am Coll Cardiol. 2019 May 7;73(17):2178-2180. doi: 10.1016/j.jacc.2018.11.068. No abstract available.

PMID:
31047005
31.

Frequency of allergic sensitization to Can f 5 in North East Italy. An analysis of 1403 ISACs 112 (Component Resolved Diagnosis) collected retrospectively.

Villalta D, Milanese M, Da Re M, Sabatino G, Sforza M, Calzetta L, Liccardi G.

Eur Ann Allergy Clin Immunol. 2019 Jul;51(4):186-189. doi: 10.23822/EurAnnACI.1764-1489.89. Epub 2019 Apr 15.

32.

Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways.

Calzetta L, Rogliani P, Page C, Rinaldi B, Cazzola M, Matera MG.

Pulm Pharmacol Ther. 2019 Jun;56:39-50. doi: 10.1016/j.pupt.2019.03.004. Epub 2019 Mar 12.

PMID:
30876907
33.

Can f 5 as a suitable marker of dog allergy: Assess male dog exposure before banning it.

Liccardi G, Calzetta L, Milanese M, Passalacqua G, Rogliani P.

J Allergy Clin Immunol. 2019 Apr;143(4):1657-1658. doi: 10.1016/j.jaci.2018.12.1007. Epub 2019 Feb 10. No abstract available.

PMID:
30745148
34.

Inhaled therapies and cardiovascular risk in patients with chronic obstructive pulmonary disease.

Rogliani P, Calzetta L, Matera MG, di Daniele N, Girolami A, Cazzola M, Ora J.

Expert Opin Pharmacother. 2019 Apr;20(6):737-750. doi: 10.1080/14656566.2019.1570133. Epub 2019 Feb 1. Review.

PMID:
30707637
35.

Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD.

Calzetta L, Cazzola M, Matera MG, Rogliani P.

Chest. 2019 Apr;155(4):758-770. doi: 10.1016/j.chest.2018.12.016. Epub 2019 Jan 17. Review.

PMID:
30660781
36.

Ensifentrine (RPL554): an inhaled 'bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease.

Cazzola M, Page C, Calzetta L, Matera MG.

Pharm Pat Anal. 2018 Nov;7(6):249-257. doi: 10.4155/ppa-2018-0030. Epub 2019 Jan 18.

PMID:
30657422
37.

LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review.

Rogliani P, Calzetta L, Braido F, Cazzola M, Clini E, Pelaia G, Rossi A, Scichilone N, Di Marco F.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 4;13:3115-3130. doi: 10.2147/COPD.S170606. eCollection 2018.

38.

Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis.

Cazzola M, Rogliani P, Calzetta L, Matera MG.

Eur Respir J. 2018 Dec 13;52(6). pii: 1801586. doi: 10.1183/13993003.01586-2018. Print 2018 Dec.

PMID:
30309975
39.

Occupational exposure to furry animals and asthma: The complex interconnection between work and everyday life.

Liccardi G, Calzetta L, Milanese M, Scaglione M, Rogliani P.

Ann Allergy Asthma Immunol. 2018 Oct;121(4):512-513. doi: 10.1016/j.anai.2018.07.039. No abstract available.

PMID:
30290895
40.

Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2).

Calzetta L, Hanania NA, Dini FL, Goldstein MF, Fairweather WR, Howard WW, Cazzola M.

Pulm Pharmacol Ther. 2018 Dec;53:20-26. doi: 10.1016/j.pupt.2018.09.007. Epub 2018 Sep 13.

41.

Indoor environmental interventions for furry pet allergens: How to decrease the degree of passive transport.

Liccardi G, Calzetta L, Milanese M, Maniscalco M, Salzillo A, Rogliani P.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1808-1809. doi: 10.1016/j.jaip.2018.05.034. No abstract available.

PMID:
30197076
42.

Allergy in adolescent population (14-18 years) living in Campania region (Southern Italy). A multicenter study.

Liccardi G, Calzetta L, Apicella G, Baldi G, Berra A, Califano F, Ciccarelli A, Cutajar M, D'Amato M, De Crescenzo G, Di Maro E, Gargano D, Giannattasio D, Inciso G, Lo Schiavo M, Madonna F, Maniscalco M, Montera C, Papa G, Pedicini A, Pio R, Salzillo A, Stanziola A, Rogliani P, Musarra A.

Eur Ann Allergy Clin Immunol. 2019 Jan;51(1). doi: 10.23822/EurAnnACI.1764-1489.65. Epub 2018 Aug 1.

43.

Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.

Calzetta L, Matera MG, Rogliani P, Cazzola M.

Expert Rev Respir Med. 2018 Aug;12(8):693-708. doi: 10.1080/17476348.2018.1495562. Epub 2018 Jul 17. Review.

PMID:
29972340
44.

Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach?

Cazzola M, Matera MG, Rogliani P, Calzetta L.

Expert Opin Investig Drugs. 2018 Jul;27(7):573-581. doi: 10.1080/13543784.2018.1492548. Epub 2018 Jul 4. Review.

PMID:
29972333
45.

Role of statins and mevalonate pathway on impaired HDAC2 activity induced by oxidative stress in human airway epithelial cells.

Matera MG, Calzetta L, Gritti G, Gallo L, Perfetto B, Donnarumma G, Cazzola M, Rogliani P, Donniacuo M, Rinaldi B.

Eur J Pharmacol. 2018 Aug 5;832:114-119. doi: 10.1016/j.ejphar.2018.05.023. Epub 2018 May 18.

PMID:
29782855
46.

Anxiety and asthma in inner-city black adolescents: What could be the underestimated, possible connection?

Liccardi G, Calzetta L, Milanese M, Salzillo A, Apicella G, Matera MG, Rogliani P.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):1093-1094. doi: 10.1016/j.jaip.2018.01.029. No abstract available.

PMID:
29747978
47.

Psychological Stress, Lung Function and Exacerbation Risk in COPD: Is an Increase of Cholinergic Tone a Possible Link?

Liccardi G, Calzetta L, Milanese M, Salzillo A, Manzi F, Ferrari M, Rogliani P.

COPD. 2018 Jun;15(3):310-311. doi: 10.1080/15412555.2018.1459533. Epub 2018 May 7.

PMID:
29733688
48.

Efficacy and safety profile of xanthines in COPD: a network meta-analysis.

Cazzola M, Calzetta L, Barnes PJ, Criner GJ, Martinez FJ, Papi A, Gabriella Matera M.

Eur Respir Rev. 2018 May 2;27(148). pii: 180010. doi: 10.1183/16000617.0010-2018. Print 2018 Jun 30. Review.

49.

The safety of dual bronchodilation on cardiovascular serious adverse events in COPD.

Rogliani P, Ora J, Matera MG, Cazzola M, Calzetta L.

Expert Opin Drug Saf. 2018 Jun;17(6):589-596. doi: 10.1080/14740338.2018.1472232. Epub 2018 May 14. Review.

PMID:
29716427
50.

Impact of doxofylline in COPD: A pairwise meta-analysis.

Cazzola M, Calzetta L, Rogliani P, Page C, Matera MG.

Pulm Pharmacol Ther. 2018 Aug;51:1-9. doi: 10.1016/j.pupt.2018.04.010. Epub 2018 Apr 26. Review.

Supplemental Content

Loading ...
Support Center